Ursodeoxycholic acid does not affect the clinical outcome of SARS-CoV-2 infection: A retrospective study of propensity score-matched cohorts.

Giuseppe Marrone Marcello Covino Giuseppe Merra Alfonso Piano Annamaria Amodeo Angela Novelli Rita Murri Maurizio Pompili Antonio Gasbarrini Francesco Franceschi

Published in: Liver international : official journal of the International Association for the Study of the Liver (2023)

UDCA treatment does not appear to have significant effects on the outcome of COVID-19. Specially designed prospective studies are needed to evaluate efficacy in preventing infection and severe disease.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
early onset
combination therapy
case control
drug induced
smoking cessation